Propranolol is used to treat high blood pressure, angina (chest pain), and irregular heartbeats. It's also used to prevent migraines and reduce anxiety symptoms.[2] Inderal is currently approved and in use across 80 indications[4].[1]
Inderal is one of 1094 small molecule programs targeting Breast Cancer. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
702 competitors in Breast Cancer
Inderal
Adenocard
Zolymbus
Lexiscan
MS Contin
MS Contin
Tricor
Acupan
Chantix
Duragesic
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
INDERAL
NDA NDA016418
Jan 1, 1982
PROPRANOLOL HYDROCHLORIDE
NDA NDA016419
Jan 9, 1984
INDERAL LA
NDA NDA018553
Mar 6, 1984
INDERAL LA
NDA NDA018553
Aug 9, 1984
INDERAL LA
NDA NDA018553
Oct 11, 1984
INDERAL LA
NDA NDA018553
Mar 21, 1985
INDERAL LA
NDA NDA018553
Apr 2, 1985
INDERAL LA
NDA NDA018553
Aug 20, 1985
INDERAL LA
NDA NDA018553
Nov 20, 1985
INDERAL LA
NDA NDA018553
Jan 7, 1986
INDERAL LA
NDA NDA018553
Mar 4, 1986
INDERAL LA
NDA NDA018553
May 27, 1986
INDERAL LA
NDA NDA018553
Sep 2, 1986
INDERAL LA
NDA NDA018553
Dec 12, 1986
INDERAL
NDA NDA019536
Jan 20, 1987
INDERAL LA
NDA NDA018553
Mar 18, 1987
INDERAL LA
NDA NDA018553
Mar 18, 1987
INDERAL LA
NDA NDA018553
May 25, 1988
INDERAL LA
NDA NDA018553
Aug 8, 1988
INDERAL LA
NDA NDA018553
Jan 25, 1989
INDERAL LA
NDA NDA018553
Apr 10, 1989
INDERAL LA
NDA NDA018553
Jun 5, 1989
INDERAL LA
NDA NDA018553
Jul 10, 1989
INDERAL LA
NDA NDA018553
Feb 9, 1990
INDERAL LA
NDA NDA018553
Apr 17, 1990
INDERAL LA
NDA NDA018553
Nov 7, 1997
INDERAL LA
NDA NDA018553
Aug 22, 1999
INDERAL LA
NDA NDA018553
Mar 31, 2000
INDERAL LA
NDA NDA018553
Feb 6, 2002
INDERAL LA
NDA NDA018553
Mar 12, 2003
INNOPRAN XL
NDA NDA021438
Mar 12, 2003
INNOPRAN XL
NDA NDA021438
Jun 9, 2004
INDERAL LA
NDA NDA018553
Oct 22, 2004
INNOPRAN XL
NDA NDA021438
Jan 3, 2007
INDERAL LA
NDA NDA018553
Feb 21, 2007
INDERAL LA
NDA NDA018553
Oct 31, 2007
INDERAL LA
NDA NDA018553
Jan 2, 2008
INNOPRAN XL
NDA NDA021438
Dec 30, 2009
INNOPRAN XL
NDA NDA021438
Dec 14, 2010
INNOPRAN XL
NDA NDA021438
Dec 14, 2010
INNOPRAN XL
NDA NDA021438
Mar 17, 2011
INDERAL LA
NDA NDA018553
Oct 24, 2013
INNOPRAN XL
NDA NDA021438
Nov 19, 2013
INNOPRAN XL
NDA NDA021438
Mar 14, 2014
HEMANGEOL
NDA NDA205410
Oct 22, 2015
INDERAL LA
NDA NDA018553
Dec 21, 2015
INDERAL LA
NDA NDA018553
Aug 16, 2021
INNOPRAN XL
NDA NDA021438
Nov 7, 2023
INDERAL LA
NDA NDA018553
Nov 7, 2023
INDERAL LA
NDA NDA018553
Dec 22, 2023
INNOPRAN XL
NDA NDA021438
Sources
Details